

631291 · 12 Rxns
Takara · Cat: 631291
Reach 3+ verified distributors
Manufacturer product page
takarabio.com/products/covid-19-research/sars-cov-2-pseudovi...
Description
Lenti-X SARS-CoV-2 Packaging Mix B.1.351 Spike, Truncated provides an extremely simple and consistent one-step method for producing high-titer lentivirus pseudotyped with the spike protein from the SARS-CoV-2 virus B.1.351 variant . No additional transfection reagent is needed because Lenti-X SARS-CoV-2 Packaging Mix B.1.351 Spike, Truncated consists of pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of lentiviral packaging plasmids. High-titer virus is produced by simply reconstituting this mixture with your lentiviral transfer vector of choice in sterile water and adding it to 293T cells e.g.,Lenti-X 293T Cells, Cat. # 632180 in a 10-cm dish. Cat. # 631291 includes 12 tubes of Lenti-X SARS-CoV-2 Packaging Mix B.1.351 Spike, Truncated and is also sold as part of Lenti-X SARS-CoV-2 Packaging Single Shots B.1.351 Spike, Truncated; Cat. # 631293 . Our products are to be used forResearch Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval. Back







